CVS HEALTH Corp
- Stock
- Ticker CVS
- ISIN US1266501006
- NYSE
Performance, volatility and drawdowns of CVS HEALTH Corp since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $14,857. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −56.8% in 12/2024, measured from the peak in 02/2022. It took 51 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 97,710 | 94,588 | 98,915 | 102,871 | 105,693 | 100,426 | 106,096 | 108,399 |
| Gross profit | 42,442 | 43,531 | 44,910 | 45,826 | 46,633 | 44,982 | 47,234 | 47,214 |
| Operating income | 2,368 | 3,374 | 2,381 | -3,207 | 2,112 | 4,680 | 4,703 | 3,566 |
| EBITDA | 3,515 | 4,528 | 3,552 | -2,073 | 3,259 | 5,795 | 5,829 | 4,698 |
| Net income | 1,644 | 1,779 | 1,021 | -3,975 | 2,943 | 2,943 | 2,979 | 2,172 |
| Earnings per share | 1.31 | 1.41 | 0.80 | -3.13 | 2.32 | 2.30 | 2.31 | 1.68 |
| Balance sheet | ||||||||
| Total assets | 253,215 | 255,585 | 258,343 | 255,327 | 253,538 | 252,974 | 253,768 | 258,075 |
| Liabilities | 177,485 | 178,475 | 180,792 | 182,217 | 178,156 | 175,337 | 173,869 | 177,386 |
| Equity | 75,560 | 76,929 | 77,379 | 72,928 | 75,214 | 77,456 | 79,702 | 80,497 |
| Cash | 8,586 | 10,076 | 11,787 | 9,098 | 8,453 | 9,542 | 11,329 | 11,738 |
| Cash flow | ||||||||
| Operating cash flow | 1,860 | 4,556 | 1,897 | 796 | 3,390 | 4,249 | 6,345 | 4,724 |
| Capital expenditure | -768 | -743 | -607 | -698 | -784 | -849 | -691 | -817 |
| Free cash flow | 1,092 | 3,813 | 1,290 | 98 | 2,606 | 3,400 | 5,654 | 3,907 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +84.3%, weakest 2024 at −40.8%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | $1.68 |
| 5 Aug 2026 | $2.31 |
| 6 May 2026 | $2.30 |
| 10 Feb 2026 | $2.32 |
| 29 Oct 2025 | −$3.13 |
| 31 Jul 2025 | $0.80 |
| 1 May 2025 | $1.41 |
| 12 Feb 2025 | $1.31 |
| 6 Nov 2024 | $0.07 |
| 7 Aug 2024 | $1.41 |
| 1 May 2024 | $0.88 |
| 7 Feb 2024 | $1.59 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €94bn
- Market cap in trading currency
- $103bn
- Enterprise value
- $88.5bn
- P/E
- 9.4
- P/S
- 0.25
- P/B
- 1.28
- EV/Sales
- 0.21
- EV/EBITDA
- 4.5
- Earnings yield
- 10.7%
- FCF yield
- 15.1%
Results (last four quarters)
- Revenue
- $421bn
- Gross profit
- $186bn
- EBITDA
- $19.6bn
- Net income
- $11.0bn
- Earnings per share
- $8.61
- Revenue per share
- $328.74
- Revenue growth
- +5.4%
- Earnings growth
- –
Profitability
- Gross margin
- 44.2%
- Operating margin
- 3.6%
- Net margin
- 2.6%
- Return on equity
- 14.4%
- Return on assets
- 4.3%
Balance sheet and cash flow
- Cash
- $14.9bn
- Cash per share
- $11.64
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 0.85
- Book value per share
- $62.91
- Operating cash flow
- $18.7bn
- Free cash flow
- $15.6bn
Dividend
- Dividend yield
- 3.29%
- Dividend (12 months)
- $2.66
- Yield (12 months)
- 3.29%
- Payout ratio
- 31%
- Ex-dividend date
- 22 Oct 2026
Shares and trading
- Shares outstanding
- 1.28bn
- Volume
- 10.4m
- Avg. volume 3 months
- 8.98m
- Relative volume
- 1.1
Price and technicals
- Price
- $80.84
- 1 day
- +1.0%
- 52-week high
- $110.60
- 52-week low
- $70.08
- Distance to 52-week high
- −26.9%
- Distance to 52-week low
- +15.4%
- Distance to 50-day line
- −8.6%
- Distance to 200-day line
- −9.5%
- RSI (14)
- 37
- Volatility 1M
- 57.8%
Performance
- 1 week
- −9.5%
- 1 month
- −14.4%
- 3 months
- −14.1%
- 6 months
- −13.3%
- YTD
- +1.9%
- 1 year
- +5.6%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has CVS performed since 11/2016?
$10,000 grew to $14,857 by 20 Nov 2026, which is +4.0% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is CVS?
Volatility was 29.8% per year, measured on monthly returns. The largest decline from a peak was −56.8%, with the low in 12/2024.
How does CVS compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CVS returned +4.0% at 29.8%. The correlation of monthly returns was 0.40; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.